In this study, pterostilbene treatment decreased the phosphorylation of IRE1a in both the IUGR colon and the TNF-α-treated Caco-2 cells, which may further inhibit the nuclear translocation of NF-κB p65 and the release of inflammatory factors. The gene discussed is ERN1; the disease is fetal growth restriction.